Author: UW CTI

The US Food and Drug Administration (FDA) finalized guidance on drug development programs for rare diseases, eliminating a section on natural history and providing additional considerations related to patient and caregiver input and pediatric populations....

To kick off the near year, UW Health is sharing key workforce, financial, care and community benefit outcomes and metrics for the health system....

A clinical trial now open at UW Health | Carbone Cancer Center uses a patient’s dying tumor cells to try to teach their immune system to find and destroy cancer cells following surgery for a type of brain cancer called glioblastoma....